Frequency of genetic polymorphism for adrenergic receptor beta and cytochrome p450 2D6 enzyme, and effects on tolerability of beta-blocker therapy in heart failure with reduced ejection fraction patients: The Beta GenTURK study

Tarih
2016
Yazar
Yucel, Ceyhun
Mutlu, Hasim
Demir, Serafettin
Ergene, Oktay
YILMAZ, MEHMET BİRHAN
ZOGHİ, MEHDİ
KAYA, HAKKI
ÇAVUŞOĞLU, YÜKSEL
Aksakal, Enbiya
Üst veri
Tüm öğe kaydını göster
Özet
Objective: The present objective was to determine frequency of Arginine389Glycine (Arg389Gly) and Cytochrome p450 2D6*10 (Cyp2D6*10) polymorphism in cases of heart failure-reduced ejection fraction (HFREF), and to evaluate the influence of the polymorphisms in response to beta-blocker (BB) therapy.
Bağlantı
http://hdl.handle.net/20.500.12627/12551
https://doi.org/10.5543/tkda.2016.10733
Koleksiyonlar